ArticleHepatology international2009

A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.

Robert G Gish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.